SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Seaport Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$17.79−0.04 (-0.22%)
Close on Oct 19, 2026
- Market cap
- $626.85M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
5 of Seaport Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 8, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |